Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Nasal congestion, Overdose, Product administered to patient of inappropriate age, Rhinorrhoea
Clinical narrative: she got sick; 9-year-old daughter received the adult Bivalent vaccine; 9-year-old daughter received the adult Bivalent vaccine; the patient did start to have a runny nose; congestion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: The reporter is the parent.  A 9-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Nov2022 as dose 4 (booster), 0.3 ml single (Lot number: GJ6739) at the age of 9 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Time: Unknown, Anatomical Site of injection: Not provided , Route of Administration: Not provided , Batch/Lot number: Not Available), administration date: Oct2021, when the patient was 8 years old, for COVID-19 Immunization; Bnt162b2 (DOSE 2, SINGLE, Date: A month after the first dose ,exact date unknown , Time: Not provided , Anatomical Site of injection: Not provided, Batch/Lot number: Not Available), when the patient was 8 years old, for COVID-19 Immunization; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE, The first booster was the regular Pfizer Covid Vaccine Booster. It was sometime in Jun2022. Lot and exp unknown to reporter.), administration date: Jun2022, when the patient was 8 years old, for COVID-19 Immunization. The following information was reported: PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious), OVERDOSE (non-serious) all with onset 18Nov2022, outcome "unknown" and all described as "9-year-old daughter received the adult Bivalent vaccine"; NASAL CONGESTION (non-serious) with onset 18Nov2022, outcome "unknown", described as "congestion"; RHINORRHOEA (non-serious) with onset 18Nov2022, outcome "unknown", described as "the patient did start to have a runny nose"; ILLNESS (non-serious), outcome "unknown", described as "she got sick". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller states that the "pharmacist called and told me he realized he had given the adult dose. He said he didn't know what to do. He said the pharmacist only put it in halfway and said it should only be put in halfway for children." Her daughter's pediatrician said it would be okay, because the higher dose was studied, and lower dose was selected because the higher dose may cause more side effects, but no long-term effects. Reporter later added, she herself got vaccinated first and the pharmacist used a regular long needle. When he was about to vaccinate the patient he got a long needle as well. Reporter thought that was odd because thought they use shorter needles for kids. The reporter was informed by the pharmacist it's the same needle, he will just put this longer needle in halfway and not all the way. She isn't sure if that's the correct way to do it. While providing details for report later in the call, reporter added the patient did start to have a runny nose, congestion on Friday and into Saturday. Reporter does not know if this is related to the booster or not. However, she got sick afterwards. They did a Covid test and it came back negative.